Laza Medical, the latest Shifamed portfolio company, announced today that it closed a Series A financing worth $36 million.
The latest positive news for a Shifamed company follows multiple milestones over the course of 2023. In June, Shifamed’s Adona Medical unveiled a next-generation heart failure management portfolio. In October, its Akura Medical unit raised $35 million for a thrombectomy system.
Laza Medical develops an imaging solution for cardiac interventions, enabled by AI and state-of-the-art robotics. The Capital Partnership (TCP) led the funding round. GE HealthCare, PA MedTech VC fund, Unorthodox Ventures and Dara holdings all participated.
Los Gatos, California-based Laza plans to use the funds to accelerate product development and further expand its team.
“The closing of this significant financing round validates the large, unmet need Laza’s solution will address, and we are grateful for the strong support of our investors,” said Amr Salahieh, founder of Shifamed and chair of Laza Medical.
Laza aims to optimize procedural workflows and elevate the standard of imaging for cardiac interventions. Its solution enables high-quality imaging and advanced procedure navigation for a broad population of clinicians.
“Obtaining high quality images of the heart is critical to improving diagnostic confidence and guiding cardiac interventions,” said Dagfinn Saetre, GM, Cardiovascular Ultrasound, GE HealthCare. “We appreciate the opportunity to participate in this funding round for Laza Medical, who is working to pioneer innovative AI, robotics and ultrasound technology to help overcome some of the most pressing cardiac imaging challenges facing clinicians today.”
More news from Laza Medical
In addition to the funding, the company announced the appointment of medtech veteran Pablo Garcia as GM.
“I am delighted to have Pablo join and lead Laza at this important time,” Salahieh said. “His wealth of knowledge and expertise in both digital products and robotics will be critical as Laza drives towards its upcoming milestones.”
Garcia has more than two decades of medical device development and leadership experience. He previously served as VP of digital solutions for Johnson & Johnson. Garcia also co-founded Verb Surgical, a J&J and Google co-venture aimed at developing surgical robotics. J&J later acquired the venture as part of its medical robotics portfolio.
“I am excited to join the Laza team and look forward to advancing this comprehensive imaging solution so that interventional operators can safely and efficiently tackle complex cases,” Garcia said. “We have assembled a strong team with expertise in robotics, software, artificial intelligence, and medical imaging, and are committed to bringing this much needed innovation to market.”
